The Truth About Avoiding 280E
Let us address the question directly: you cannot avoid Section 280E. There is no legal structure, no accounting trick, and no tax strategy that eliminates 280E's application to a business whose revenue derives from trafficking in a Schedule I controlled substance. Cannabis remains classified as Schedule I under the federal Controlled Substances Act as of 2025, and until that classification changes through either congressional rescheduling or descheduling, every cannabis business in the United States operates under 280E's restrictions.
What you can do, and what every well-advised cannabis operator should be doing, is legally minimize the financial impact of 280E. The difference between a cannabis business that takes a naive approach to 280E and one that implements sophisticated, defensible tax strategies can be $100,000 to $500,000 or more per year in tax savings, depending on revenue and operation type. For a dispensary doing $5 million in annual revenue, the gap between a poorly optimized 280E position and a well-optimized one can mean the difference between a 70% effective tax rate and a 45% effective tax rate. That gap represents real cash that either stays in the business or goes to the IRS.
The strategies outlined in this guide are used by our clients at Northstar Financial and are grounded in the Internal Revenue Code, IRS guidance, and Tax Court precedent. None of them involve fabricating deductions or misclassifying expenses. All of them require meticulous documentation, professional oversight, and the discipline to stay within the boundaries of what the IRS has accepted as defensible. The operators who try to push beyond those boundaries, and there are many, routinely find themselves in audit situations that cost far more than the taxes they were trying to avoid.
Understanding What 280E Actually Prohibits
Section 280E is a remarkably simple piece of tax law. It states: "No deduction or credit shall be allowed for any amount paid or incurred during the taxable year in carrying on any trade or business if such trade or business (or the activities which comprise such trade or business) consists of trafficking in controlled substances (within the meaning of schedule I and II of the Controlled Substances Act) which is prohibited by Federal law or the law of any State in which such trade or business is conducted."
The critical phrase is "no deduction or credit." This means that ordinary and necessary business expenses that any other business would deduct, including rent, utilities, marketing, administrative salaries, insurance, professional fees, office supplies, and every other category of operating expense, are non-deductible for a cannabis business. In a normal business, these expenses reduce taxable income. Under 280E, they do not. The business pays federal income tax as if these expenses did not exist.
However, 280E does not override Section 471 of the Internal Revenue Code, which governs inventory accounting and allows cannabis businesses to include in COGS all costs related to procuring, securing, and maintaining inventory. The IRS has consistently acknowledged that cannabis businesses may deduct their cost of goods sold (COGS), because COGS is technically an adjustment to gross receipts rather than a "deduction" in the statutory sense. This distinction, between expenses that are deductions (disallowed under 280E) and costs that are part of COGS (permitted), is the foundation of every legitimate 280E minimization strategy.
How a 280E Cost Study Can Save You Thousands
A 280E cost study is a formal analysis, conducted by a CPA with cannabis tax expertise, that identifies every cost in your operation that can legitimately be classified as part of cost of goods sold under Section 471's inventory cost rules and the applicable Treasury Regulations. The goal is to ensure that you are capturing every allowable COGS component, not just the obvious ones, and that your allocation methodology is documented, consistent, and defensible.
For cultivation operations, the universe of potentially allocable COGS costs is substantial. Direct materials including seeds, clones, growing medium, nutrients, pesticides, and beneficial insects are straightforward COGS items. Direct labor, meaning wages and benefits for employees whose primary duties involve planting, growing, harvesting, trimming, curing, and packaging cannabis, is also clearly COGS. But the cost study extends into indirect production costs that many operators miss: utilities allocated to grow rooms (electricity for lights, HVAC, and dehumidification; water; natural gas), rent or depreciation allocated to production areas based on square footage, equipment depreciation for cultivation-specific assets, quality assurance and testing costs, and even supervisory labor for managers who oversee production employees.
A thorough cost study for a cultivation operation typically identifies 15% to 40% more in allowable COGS than the operator was claiming before the study. For a cultivator with $3 million in revenue, that increase could translate to $50,000 to $150,000 in additional tax savings per year. The cost study itself typically costs $5,000 to $15,000 depending on the complexity of the operation, making it one of the highest-return investments a cannabis business can make.
For dispensaries, the COGS universe is narrower but still benefits from professional analysis. The primary COGS component is the wholesale cost of inventory purchased for resale. Secondary components include inbound freight and transportation costs, receiving and inspection labor, and storage costs directly attributable to inventory areas. Some dispensaries have also successfully argued that the labor cost of inventory management, specifically the time employees spend receiving, verifying, logging, and stocking inventory rather than selling it, qualifies as COGS under the acquisition cost theory established in the CHAMP v. Commissioner Tax Court case.
What Makes a Cost Study Defensible in an Audit
The IRS does not accept cost studies at face value. In an audit, the examiner will scrutinize the methodology, the supporting documentation, and the reasonableness of the allocations. A defensible cost study must be based on actual, contemporaneous data rather than estimates or retroactive allocations. Utility allocations should be supported by sub-metering data or engineering studies that calculate energy consumption by area based on equipment specifications and operating hours. Labor allocations should be supported by time-tracking records that capture employee activity at a level of detail sufficient to distinguish production time from non-production time. Square footage allocations should be documented with floor plans that clearly delineate production areas from administrative and retail areas.
The IRS has successfully challenged cost studies that rely on round-number allocations (claiming exactly 50% of rent as COGS without supporting calculation), that use industry averages rather than company-specific data, or that allocate costs to COGS that have no reasonable connection to production or inventory acquisition. Investing in a properly conducted cost study is essential; cutting corners on the study itself defeats its purpose.
COGS Allocation Optimization by License Type
The COGS optimization strategy varies significantly depending on whether the operation is a cultivator, manufacturer, distributor, or retailer. Each license type has a different cost structure, and the IRS applies different standards to each.
Cultivation COGS Optimization
Cultivators have the broadest universe of allocable COGS costs because their production activities generate significant costs of procuring, securing, and maintaining inventory under Section 471. The key optimization lever is indirect production cost allocation, which captures facility costs, utility costs, and supervisory labor that would otherwise be classified as non-deductible operating expenses. The allocation methodology must be reasonable and consistent, but within those constraints, a well-structured allocation can shift substantial costs from the non-deductible category to COGS.
For example, consider a cultivation facility occupying 20,000 square feet, of which 15,000 square feet is dedicated to grow rooms and processing areas, and 5,000 square feet is used for offices, break rooms, and storage. Under a square-footage allocation, 75% of the facility's rent, property taxes, insurance, and common-area utilities can be allocated to COGS. If annual rent is $360,000, that allocation shifts $270,000 from non-deductible rent expense to deductible COGS, saving the business approximately $56,700 to $81,000 in federal taxes depending on the entity's marginal rate.
Electricity is often the largest utility cost for indoor cultivators, and proper allocation can be the single most impactful element of a cost study. A 20,000-square-foot indoor cultivation facility in California might spend $15,000 to $30,000 per month on electricity. If sub-metering or engineering analysis shows that 85% of that electricity powers grow lights, HVAC, and dehumidification in production areas, the cultivation operation can allocate approximately $153,000 to $306,000 per year in electricity costs to COGS.
Dispensary COGS Optimization
Dispensaries have a more limited COGS base because they are retail operations rather than producers. The wholesale cost of inventory is the primary COGS component, and there is limited room for optimization there. However, several secondary cost allocations can meaningfully increase a dispensary's COGS position.
Inventory acquisition costs include everything the dispensary spends to get product from the supplier onto its shelves. Transportation costs for pickup orders, delivery fees charged by distributors, inspection and verification labor (the time employees spend counting and logging incoming shipments against METRC manifests), and storage costs for dedicated inventory areas all potentially qualify. For a dispensary receiving $1.5 million to $3 million in wholesale inventory per year, these secondary acquisition costs might add $30,000 to $80,000 to the COGS base.
The CHAMP v. Commissioner case (T.C. Memo 2007-323) established that a cannabis business may separate its trafficking activities from non-trafficking activities for 280E purposes, provided the non-trafficking activities constitute a genuinely separate trade or business. This precedent is the foundation for the ancillary business strategy discussed below.
Entity Structuring Strategies for 280E Minimization
The choice of business entity has meaningful 280E implications that many operators overlook or misunderstand. The three most common structures, C-Corporation, S-Corporation, and LLC, each interact with 280E differently.
Why C-Corporation Is Often the Best 280E Structure
A C-Corporation is a separate taxable entity that pays taxes at its own level. Under 280E, the C-Corp pays federal income tax at 21% on its gross profit (revenue minus COGS), without the benefit of deducting operating expenses. The owners of the C-Corp then receive compensation in the form of wages, which are deductible to the corporation as part of its cost structure, or dividends, which are taxed at the preferential qualified dividend rate of 15% to 20% at the individual level.
The 280E advantage of the C-Corp structure arises from the fact that reasonable compensation paid to owner-employees is deductible as COGS if the owner's duties are directly related to production or inventory acquisition. A cultivation company owner who spends 70% of their time on grow operations can allocate 70% of their compensation to COGS, reducing the corporation's taxable gross profit. This double benefit, corporate-level COGS deduction plus the individual's ability to deduct ordinary living expenses against wage income, makes the C-Corp the preferred structure for most cannabis operations with annual revenue above $1 million.
S-Corporation and LLC Pitfalls Under 280E
S-Corporations and LLCs taxed as partnerships are pass-through entities, meaning the business's income flows through to the owners' personal tax returns. Under 280E, the non-deductible operating expenses also flow through to the owners, who end up paying tax on income that was largely consumed by business expenses they cannot deduct. This creates the perverse situation where an owner reports $500,000 in taxable income on their personal return but actually received only $100,000 in distributions because the other $400,000 was consumed by non-deductible operating expenses.
For this reason, cannabis CPAs generally recommend against S-Corp and LLC structures for plant-touching cannabis businesses, particularly those with significant operating expenses relative to COGS. The conversion from an S-Corp or LLC to a C-Corp is a taxable event that must be carefully structured, but the long-term 280E savings typically far exceed the one-time conversion cost.
The Ancillary Business and Management Company Strategy
One of the most widely discussed 280E strategies is the creation of a separate non-cannabis ancillary business or management company that provides services to the cannabis entity. The theory is straightforward: if certain business functions (management, marketing, administration, real estate) are performed by a separate entity that does not itself traffic in controlled substances, that entity's expenses are fully deductible because 280E does not apply to it.
How Management Company Structures Work
In a typical management company structure, the cannabis operator creates a second entity, often an LLC or S-Corp, that employs administrative staff, holds the real estate lease, owns non-cannabis equipment, and provides management services to the cannabis entity under a formal management agreement. The cannabis entity pays a management fee to the management company, and that fee is either classified as COGS (if the management services relate to production) or as a non-deductible expense (if they relate to general operations). Meanwhile, the management company deducts its own operating expenses, including the salaries, rent, insurance, and other costs that would be non-deductible if they sat inside the cannabis entity, against the management fee income.
When properly structured, this arrangement can shift $200,000 to $1 million or more in expenses from the non-deductible cannabis entity to the fully deductible management company, depending on the size of the operation. The tax savings can be dramatic.
Why This Strategy Requires Extreme Care
The IRS is acutely aware of management company structures and has challenged them aggressively in cannabis audits. To survive scrutiny, the management company must have genuine economic substance. This means it must be a real business with its own bank accounts, its own employees, its own contracts, and a management fee that reflects fair market value for the services actually provided. A management company that exists only on paper, that has no employees, that charges a management fee equal to exactly the cannabis entity's operating expenses, or that provides no services beyond what the cannabis entity's own staff could perform, will be disregarded by the IRS as a sham.
The Tax Court's decision in Californians Helping to Alleviate Medical Problems (CHAMP) v. Commissioner established that a business can separate its cannabis activities from non-cannabis activities for 280E purposes, but only if the non-cannabis activities constitute a genuine, separate trade or business with its own customers, revenue potential, and economic rationale. Subsequent cases have reinforced this standard, and the IRS has become increasingly sophisticated in identifying management company structures that lack substance.
At Northstar Financial, we help clients evaluate whether a management company structure is appropriate for their specific situation, design the entity structure to maximize defensibility, set management fees at arm's-length levels supported by comparable market data, and maintain the documentation and operational separation that the IRS requires. Not every cannabis operation benefits from this strategy, and implementing it incorrectly creates more risk than it eliminates.
What Strategies Cross the Line from Aggressive to Illegal
The line between aggressive tax optimization and tax fraud is not always bright, but certain 280E strategies cross it clearly and should be avoided entirely.
Classifying all employee wages as COGS is the most common overreach. Some operators classify 100% of their payroll as production labor, even for employees who spend their days behind a counter, answering phones, or performing administrative tasks. The IRS will examine time records, job descriptions, and actual duties, and any allocation that does not reflect reality will be adjusted with penalties.
Creating sham ancillary businesses that exist only to absorb non-deductible expenses without performing genuine business activities is fraudulent. An operator who creates a "consulting company" that has no clients other than the cannabis entity, performs no services beyond what the cannabis entity's own staff does, and charges fees exactly equal to the expenses it needs to absorb is setting up an audit adjustment and potential fraud referral.
Fabricating or inflating COGS documentation by creating fictitious invoices, overstating inventory quantities, or manipulating cost-accounting records is criminal tax fraud. The IRS Criminal Investigation division has successfully prosecuted cannabis operators for these activities, and the penalties include not just back taxes and civil penalties but also criminal fines and imprisonment.
Double-counting deductions by claiming the same cost as both COGS inside the cannabis entity and as an operating expense inside a management company is another pattern the IRS watches for. Intercompany transactions must eliminate on consolidation, and every dollar of cost must live in one entity or the other, never both.
The penalties for aggressive 280E positions that the IRS successfully challenges range from a 20% accuracy-related penalty for negligence or substantial understatement of income to a 75% civil fraud penalty for intentional misrepresentation. Combined with interest on the underpayment, a failed aggressive strategy can cost the operator two to three times the taxes they were trying to avoid.
How Rescheduling or Descheduling Would Affect 280E
The DEA's proposed reclassification of cannabis from Schedule I to Schedule III, announced in 2024, would fundamentally change the 280E landscape if finalized. Section 280E applies only to Schedule I and Schedule II substances, so reclassification to Schedule III would eliminate 280E's application to cannabis entirely. Cannabis businesses would become eligible to deduct all ordinary and necessary business expenses, just like any other legal business.
However, as of early 2025, rescheduling has not been finalized. The proposed rule is undergoing public comment and administrative review processes that could take months or years to complete, and it is subject to legal challenges from multiple parties. Cannabis operators should not make current tax decisions based on the assumption that rescheduling will occur on any specific timeline.
If and when rescheduling does take effect, the transition will raise complex questions about amended returns, refund claims for prior years, and the appropriate accounting treatment for the change. Operators who have maintained clean, well-documented books with proper 280E classification will be in the best position to claim refunds and take advantage of the new deduction landscape. Operators whose books are a mess will struggle to reconstruct the information needed to file amended returns.
The best strategy is to optimize your 280E position fully under current law while maintaining the documentation and financial infrastructure that will allow you to pivot quickly when the law changes. At Northstar Financial, we prepare our clients for both realities: minimizing their 280E burden today while positioning them to capture the full benefit of rescheduling when it arrives.